CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 230 filers reported holding CONMED CORP in Q1 2023. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,857,450 | +30.8% | 205,000 | 0.0% | 0.66% | +30.5% |
| Q1 2023 | $21,291,300 | +17.2% | 205,000 | 0.0% | 0.51% | +16.2% |
| Q4 2022 | $18,171,200 | -2.7% | 205,000 | -12.0% | 0.44% | -9.3% |
| Q3 2022 | $18,680,000 | -12.5% | 233,000 | +4.5% | 0.48% | -22.4% |
| Q2 2022 | $21,354,000 | -29.0% | 223,000 | +10.1% | 0.62% | -18.0% |
| Q1 2022 | $30,081,000 | +4.8% | 202,500 | 0.0% | 0.76% | +14.2% |
| Q4 2021 | $28,706,000 | +35.0% | 202,500 | +24.6% | 0.66% | +48.3% |
| Q3 2021 | $21,260,000 | -4.8% | 162,500 | 0.0% | 0.45% | +1.4% |
| Q2 2021 | $22,332,000 | +101.0% | 162,500 | +91.0% | 0.44% | +82.2% |
| Q1 2021 | $11,111,000 | +27.2% | 85,085 | +9.1% | 0.24% | +30.8% |
| Q4 2020 | $8,736,000 | -38.3% | 78,000 | -56.7% | 0.18% | -48.5% |
| Q3 2020 | $14,161,000 | +9.3% | 180,000 | 0.0% | 0.36% | +1.1% |
| Q2 2020 | $12,958,000 | +25.7% | 180,000 | 0.0% | 0.36% | -16.7% |
| Q1 2020 | $10,309,000 | – | 180,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |